|Articles|June 1, 2002

Protection Across the Cardiovascular Continuum: What Can Be Done for Patients at Risk?
Volume 8
Issue 9 Suppl

Introduction

Author(s)Peter F. Cohn, MD

Download PDF: Introduction

Articles in this issue

over 24 years ago

Article

Cardioprotection: What Is It? Who Needs It?

over 24 years ago

Article

Beta Blockers as Cardioprotective Agents: Part I -- Insights into Mechanisms of Action

over 24 years ago

Article

Beta Blockers as Cardioprotective Agents: Part II -- Focus on Prevention of Sudden Cardiac Death

over 24 years ago

Article

Statins as Cardioprotective Agents

over 24 years ago

Article

ACE Inhibitors as Cardioprotective Agents

over 24 years ago

Article

Role of Antiplatelet Agents in Cardioprotection

over 24 years ago

Article

Call to Action

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Introduction

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

MFN Drug Agreements Could Raise Prices Worldwide

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

60% of US Women Face Barriers to Postpartum, Mental Health Care